Q: I know in your last answer you indicated you had simply run out of patience with GUD. Wondering what your thoughts are now ? Outside of some major move (maybe a buyout or privatization) do you see much chance for significant capital appreciation over the next year. I'm down over $5K on 2000 shares ...wondering if I should just move on ...and if so, any suggestions (maybe HHL) ?
You can view 2 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hello 5i team,
Your thoughts on Knight's latest earnings? Is there any life left in this stock?
Thanks,
Andrew
Your thoughts on Knight's latest earnings? Is there any life left in this stock?
Thanks,
Andrew
Q: Curious to see Knight back to all time lows despite so much promise in years past with all their cash and careful approach; we sold it long ago but wonder what did or didn't happen here ?
Q: WELL reported this morning. Looked strong across the board. Can you comment and provide your thoughts before call later today.
Q: Hi Peter
What are the expectations for WELL financials (REV and Adj EBITDA) for Q4 and Full Year. Also at these price levels is it a buy, sell or hold.
Thank you
What are the expectations for WELL financials (REV and Adj EBITDA) for Q4 and Full Year. Also at these price levels is it a buy, sell or hold.
Thank you
Q: hello 5i:
recently, I asked a question about LIFE; thanks for the quick response. In hindsight, what I should have asked might have been: which covered call ETF, in the health care space, provides the best dividend rate, with the lowest return of capital. As we're dealing in registered accounts, return of capital is not of interest to me.
thanks
Paul L
recently, I asked a question about LIFE; thanks for the quick response. In hindsight, what I should have asked might have been: which covered call ETF, in the health care space, provides the best dividend rate, with the lowest return of capital. As we're dealing in registered accounts, return of capital is not of interest to me.
thanks
Paul L
Q: Your thoughts please on the latest quarter?
Thx
Thx
Q: WELL down 5%+ of heavy volume late Wednesday. Don't see any news. Any explanation for the move?
- Amgen Inc. (AMGN)
- CVS Health Corporation (CVS)
- Eli Lilly and Company (LLY)
- UnitedHealth Group Incorporated (DE) (UNH)
- Ninepoint Energy Income FUnd (NRGI)
Q: Hi group i presently hold CVS - 20% loss,- UNH - 11% loss Buy sell or old ? + if sell what would you replace with (these are my only holds in health sector this sector is really struggling - your comments on the sector + these 2 stocks in general
I also own NRGI - presently a 20% loss I also own ARC in this sector presently 5% loss - your thoughts on the sector in general + But sell or Hold
thanks for your help with my portfolio
I also own NRGI - presently a 20% loss I also own ARC in this sector presently 5% loss - your thoughts on the sector in general + But sell or Hold
thanks for your help with my portfolio
Q: Hello 5i,
I have reviewed the questions on these two ETF's and I would like to confirm my thinking. I need to increase both my international and U.S. sectors, one more than the other. As I understand it, if I purchase LIFE, then my international sector would improve over HHL and if I purchase HHL, then my U.S. sector would improve over LIFE. Beyond geographic sector allocation I am largely indifferent albeit with a slight preference for HHL more due to its MER more than anything else.
So, are my assumptions correct and would you have anything further to add in terms of preferring one over the other that I may have overlooked?
Many thanks as always!!!
Cheers,
Mike
I have reviewed the questions on these two ETF's and I would like to confirm my thinking. I need to increase both my international and U.S. sectors, one more than the other. As I understand it, if I purchase LIFE, then my international sector would improve over HHL and if I purchase HHL, then my U.S. sector would improve over LIFE. Beyond geographic sector allocation I am largely indifferent albeit with a slight preference for HHL more due to its MER more than anything else.
So, are my assumptions correct and would you have anything further to add in terms of preferring one over the other that I may have overlooked?
Many thanks as always!!!
Cheers,
Mike
Q: I bought this stock a few years back, it pays a consistent dividend but little value add outside of that. I am thinking of selling and moving into other US pharma with better growth upside. What are your thoughts and a couple of recommendations for alternatives.
As always thanks for your advise.
Jim
As always thanks for your advise.
Jim
Q: When does WELL intend to release 4th quarter and year end 2022 financial results?
Q: CSTL Could you comment on earnings, revs are up 53 %, they guided to almost double them by 2025. Business here looks good. Cash flow did decrease based on acquisitions... is this a company building a profitable, invest-able future? Your thoughts?
- Intuitive Surgical Inc. (ISRG)
- AbbVie Inc. (ABBV)
- Abbott Laboratories (ABT)
- Merck & Company Inc. (MRK)
- Pfizer Inc. (PFE)
- Thermo Fisher Scientific Inc (TMO)
- Novo Nordisk A/S (NVO)
Q: How about buying this high multiple stock in this market. Is it still the leader in it's field.
Need to buy 2 stocks in healtcare. One growth one income. PFE is around 52 week low with a 4.1% dividend.
Would like to know your favorites at this time.
Thanks for your support in these uncertain times!
Need to buy 2 stocks in healtcare. One growth one income. PFE is around 52 week low with a 4.1% dividend.
Would like to know your favorites at this time.
Thanks for your support in these uncertain times!
Q: Good morning,
Can you please give us your opinion on Profound Medical after their earnings miss this week? Is it still worth holding, or do you feel the cash burn will require share issues and resulting dilution. Thank you.
Can you please give us your opinion on Profound Medical after their earnings miss this week? Is it still worth holding, or do you feel the cash burn will require share issues and resulting dilution. Thank you.
Q: PFE’s stock value has been declining. Do you have any insight as to what cause that?
Thanks,
Roger
Thanks,
Roger
Q: WELL bought Circle Medical out of Silicon Valley. How exposed do you believe WELL is to the SVB banking collapse ?
Thank You for you great efforts during these unpredictable times
Thank You for you great efforts during these unpredictable times
- Regeneron Pharmaceuticals Inc. (REGN)
- Johnson & Johnson (JNJ)
- Eli Lilly and Company (LLY)
- Merck & Company Inc. (MRK)
- Pfizer Inc. (PFE)
- Thermo Fisher Scientific Inc (TMO)
- Novo Nordisk A/S (NVO)
- iShares Biotechnology ETF (IBB)
- Moderna Inc. (MRNA)
- VANECK ETF TR (BBH)
- iShares U.S. Pharmaceuticals ETF (IHE)
Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.
Q: Pfizer is very weak over the last month or two. Any reasons other than maybe some market repositioning? Thanks
- iShares Global Healthcare ETF (IXJ)
- Health Care Select Sector SPDR (XLV)
- Evolve Global Healthcare Enhanced Yield Fund (LIFE)
Q: I know that you have suggested the US for healthcare sector exposure given the somewhat limited opportunities in Canada. I struggle a bit with the single company risks in the sector given the possible reversals in fortune with political policy decisions, failures with trials and products in the pipeline, lawsuits etc. etc. Can you suggest two or three ETFs that cover the the entire Healthcare universe (devices, pharmaceuticals, biotech, health insurance carriers and/or whatever else makes up the sector) reasonably well. Thank you!